Ubiquitination in Control of EGF Receptor Endocytosis by Bertelsen, Vibeke
Ubiquitination in Control of
EGF Receptor Endocytosis
by
Vibeke Bertelsen 
Laboratory for Molecular and Cellular Cancer Research,
Institute of Pathology, Faculty Division Rikshospitalet, 
Faculty of Medicine, University of Oslo, Norway 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Vibeke Bertelsen, 2009 
 
 
Series of dissertations submitted to the  
Faculty of Medicine, University of Oslo 
No. 727 
 
ISBN 978-82-8072-774-9 
 
 
All rights reserved. No part of this publication may be  
reproduced or transmitted, in any form or by any means, without permission.   
 
 
 
 
 
 
 
 
Cover: Inger Sandved Anfinsen. 
Printed in Norway: AiT e-dit AS, Oslo, 2009.   
 
Produced in co-operation with Unipub AS.  
The thesis is produced by Unipub AS merely in connection with the  
thesis defence. Kindly direct all inquiries regarding the thesis to the copyright  
holder or the unit which grants the doctorate.   
 
Unipub AS is owned by  
The University Foundation for Student Life (SiO) 
ACKNOWLEDGEMENTS
The present work has been carried out at the Laboratory for Molecular and Cellular Cancer Research, 
Institute of Pathology, Faculty Division Rikshospitalet, University of Oslo, during the period 2003-
2008. I am grateful for the financial support for this project which was mainly provided by The 
Norwegian Cancer Society. 
First I want to express my gratitude to my supervisor Professor Inger Helene Madshus and to 
my co-supervisor Dr. Espen Stang for giving me the opportunity to work in your group and in such an 
interesting field of research. I truly appreciate your guidance, support and enthusiasm, and for always 
being available for questions and discussions whenever it was needed. Inger Helene, I also want to 
thank you for providing additional financial support enabling me to complete this study and for 
believing in me. I’m happy for getting the opportunity to continue to work in you group. Espen, I truly 
appreciate your beautiful EM-experiments. They have been extremely valuable for this work. It is 
always a great relief when important results can be confirmed by your lovely pictures. I will also thank 
you for your patience and for all help with big things and small –but invaluable– details all the way.   
This work would not have been performed without the help of countless generous helpful people. 
Sincere thanks to  
o All the co-authors of the papers included in this thesis. Without your contribution, 
this study would of course not have been possible. 
o Lene E. Johansen for always sharing your knowledge and being willing to help 
out and take time to answer my endless questions. 
o Marianne S. Rødland for providing assistance in numerous ways at all stages, I 
really appreciate your help and friendship. 
o Malgorzata M. Sak for your great enthusiasm and for being so sweet and hard-
working. The effort you put in to help me finish this work is priceless.  
o Kamilla Breen and Michael V. Grandal for reading this thesis at various stages 
and providing invaluable feedback   
I am grateful to all my former and present colleagues at the institute and in the Madshus’ group. 
Without such a pleasant and friendly environment, this work would at many stages have been 
unbearable. Particularly, I want to mention and thank Maja Kazazic and Lene M. Grøvdal for being 
fantastic colleagues, friends and traveling partners during this period, Michael V. Grandal for all 
fruitful discussions, for creating an amusing working environment in our lab during your stay and for 
being a good friend and my music soul-mate, Camilla Stormo for being the sweetest master student, a 
good friend and for all your questions which made me a better researcher. Finally, Anders Sandvik and 
Alexander Erofeev are thanked for being so nice office mates. Anders, having you around in the office 
all weekends and late nights made the last year much easier.      
Nina Marie Pedersen and Kamilla Breen, thank you both for being wonderful friends. Your presence 
has been very important to me during this period. You have followed me all the way through all hard 
and good times; I can not imagine how I could have managed to fulfill this work without you being 
there for me. Thank you!  
Thanks also to my friends outside the laboratory and my family. Thank you all for all the good times 
we have shared, for support and encouragement. My family is especially appreciated for helping out 
with my family life, your help made it possible for me to concentrate on my work whenever needed. A 
special and warm thank to ‘my two boys’ Pål-André and Mads, for unconditional support and for your 
endless patience, generosity, encouragement and love.  
Oslo, August 2008 
Vibeke Bertelsen 
 
TABLE OF CONTENTS 
 
TABLE OF CONTENTS 
ABBREVIATIONS..................................................................................................................... II 
PAPERS INCLUDED ............................................................................................................... III 
1 INTRODUCTION ........................................................................................................... 1 
1.1 THE ERBB FAMILY OF RECEPTOR TYROSINE KINASES............................................. 1 
1.1.1 EGFR................................................................................................................... 3 
1.1.2 EGFR activation and signal transduction............................................................ 4 
1.1.3 Ubiquitination of EGFR ...................................................................................... 5 
1.2 ENDOCYTOSIS........................................................................................................... 7 
1.2.1 Clathrin-mediated endocytosis ............................................................................ 8 
1.2.2 Clathrin-independent endocytosis ..................................................................... 11 
1.2.3 Ubiquitination as endocytic signal .................................................................... 12 
1.2.4 Endocytic down-regulation of EGFR................................................................ 13 
1.3 EGFR IN CANCER................................................................................................... 18 
2 AIMS OF THE STUDY.................................................................................................. 20 
3 SUMMARY OF PAPERS............................................................................................... 21 
3.1 PAPER I................................................................................................................... 21 
3.2 PAPER II ................................................................................................................. 22 
3.3 PAPER III ................................................................................................................ 22 
3.4 PAPER IV................................................................................................................ 23 
4 METHODOLOGICAL CONSIDERATIONS .................................................................... 25 
4.1 CELL LINES/EXPERIMENTAL CELL SYSTEMS.......................................................... 25 
4.2 TRANSIENT TRANSFECTION WITH PLASMIDS AND OVEREXPRESSION OF PROTEINS 26 
4.3 RNA INTERFERENCE (RNAI) ................................................................................. 26 
4.4 IMMUNOLOGICAL METHODS .................................................................................. 27 
4.5 MICROSCOPY.......................................................................................................... 28 
4.6 INTERNALIZATION OF EGF..................................................................................... 30 
5 GENERAL DISCUSSION .............................................................................................. 31 
5.1 SIGNALS FOR EGFR ENDOCYTOSIS ........................................................................ 31 
5.1.1 Is EGFR kinase activity required for EGFR endocytosis?................................ 31 
5.1.2 Is ubiquitination of EGFR necessary for its endocytosis? ................................ 32 
5.2 TRANSLOCATION OF EGFR INTO CLATHRIN-COATED PITS .................................... 36 
5.3 CONCLUDING REMARKS......................................................................................... 38 
REFERENCES ......................................................................................................................... 39 
ABBREVIATIONS 
 
 
ABBREVIATIONS 
AP-2    Adaptor protein 2 
EEA1         Early endosomal antigen 1 
EGF    Epidermal growth factor 
EGFR    Epidermal growth factor receptor 
EH    Epsin homology 
ENTH    Epsin N-terminal homology  
ESCRT   Endosomal Sorting Complexes Required for Transport 
GFP    Green fluorescent protein 
GGA(s)   Golgi-associated, -adaptin homologue(s) 
GH    Growth hormone 
GHR    Growth hormone receptor 
GPI    Glycosyl phosphatidylinositol  
Hrs    Hepathocyte growth factor regulated tyrosine kinase substrate 
Immuno-EM   Immuno-electron microscopy 
LDL    Low density lipoprotein 
LDLR    Low density lipoprotein receptor 
MAPK   Mitogen-activated protein kinase 
MHC-I   Major histocompatibility complex class I 
MVB(s)   Multivesicular body(ies) 
PAE    Porcine Aortic Endothelial     
PI3K    Phosphatidylinositol 3-kinase 
PIP2    Phosphatidylinositol 4,5-bisphosphate 
PLC    Phospholipase C 
PLD    Phospholipase D 
PRD    Proline rich domain 
PTB    Phosphotyrosine binding 
RNAi    RNA interference 
RTK    Receptor tyrosine kinase 
SH    Src homology 
siRNA    Short interfering RNA 
STAM    Signal-transducing adaptor molecule  
STAT    Signal transducer and activator of transcription 
Tf    Transferrin 
TfR    Transferrin receptor 
TGF    Transforming growth factor alpha    
TGN    Trans-Golgi network 
TULA    T-cell ubiquitin ligand 
UIM    Ubiquitin interacting motif  
 
II 
PAPERS INCLUDED 
 
PAPERS INCLUDED 
Paper I Vibeke Bertelsen, Kamilla Breen, Kirsten Sandvig, Espen Stang, and Inger 
Helene Madshus.  
 
The Cbl-binding protein TULA inhibits dynamin-dependent endocytosis.  
 
Experimental Cell Research, Vol 313, 1696-1709, May 2007.
 
 
 
Paper II Espen Stang, Frøydis D. Blystad, Maja Kazazic, Vibeke Bertelsen, Tonje 
Brodahl, Camilla Raiborg, Harald Stenmark, and Inger Helene Madshus 
 
Cbl-dependent ubiquitination is required for progression of EGF Receptors 
into clathrin-coated pits. 
 
  Molecular Biology of the Cell, Vol 15, 3591-3604, August 2004. 
 
 
 
Paper III Maja Kazazic*, Vibeke Bertelsen*, Ketil Winther Pedersen, Tram Thu 
Vuong, Michael Vibo Grandal, Marianne Skeie Rødland, Linton M. Traub, 
Espen Stang, and Inger Helene Madshus 
* These authors contributed equally to this work 
 
Epsin recruits ubiquitinated EGF receptors into clathrin-coated pits. 
 
Revised manuscript submitted (Traffic) 
 
 
Paper IV Vibeke Bertelsen, Malgorzata Magdalena Sak, Kamilla Breen, Espen Stang, 
and Inger Helene Madshus. 
 
 Cbl and Ubiquitin promote translocation of EGF Receptor into clathrin-
coated pits. 
 
  Manuscript
 III
 
 
 
IV 
INTRODUCTION  
 
1 INTRODUCTION 
Cells are continuously supplied with information from other cells and the 
microenvironment, and this information is often in the form of signaling molecules like 
hormones, cytokines and growth factors. It is important that the interpretation of this 
information is correct to maintain homeostasis, normal growth and development, as well as 
cell survival. Signaling molecules affect the target cell by binding to receptors localized to 
the plasma membrane, and the receptors then translate the signals from extracellular stimuli 
to intracellular messages. One major family of receptors for growth factors is the family of 
receptor tyrosine kinases (RTKs) which consists of approximately 20 different subclasses. 
To avoid excessive cell growth, it is essential to attenuate the signaling downstream of such 
growth factor receptors. One way of attenuating signaling is down-regulation of activated 
receptors by endocytosis. In this work, the focus has been on endocytic down-regulation of 
the epidermal growth factor receptor (EGFR), which belongs to the ErbB family of receptor 
tyrosine kinases. 
1.1 THE ERBB FAMILY OF RECEPTOR TYROSINE KINASES 
The ErbB family comprises the subclass I of the receptor tyrosine kinases. There are four 
members of this family: EGFR (also called ErbB1 or HER1), ErbB2 (also called Neu or 
HER2), ErbB3 (also called HER3) and ErbB4 (also called HER4). These ErbB proteins are 
expressed in cells of epithelial, mesenchymal and neuronal origin, and they are shown to be 
involved in development, proliferation and differentiation (reviewed in Olayioye et al. 
2000). The different ErbB proteins have approximately 40 % sequence similarity (Stein and 
Staros 2000) and share the same overall protein structure. They contain a highly 
glycosylated extracellular domain with a ligand-binding region and a dimerization loop, a 
transmembrane domain, and a cytoplasmic domain with tyrosine kinase activity (reviewed 
in Olayioye et al. 2000; Burgess et al. 2003). Although they exhibit structural similarity, the 
different ErbB proteins differ with respect to a variety of properties, such as ligand-binding, 
kinase activity, and signaling pattern and are thus thought to have distinct physiological 
roles. 
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The ErbB proteins are activated upon ligand binding. Binding of ligand induces a 
conformational change in the extracellular domain of the ErbB proteins causing the 
dimerization loop to be exposed and thereby allowing the ErbB proteins to form dimers, 
either homodimers or heterodimers. All high-affinity ligands of the ErbB family of receptors 
belong to the epidermal growth factor (EGF) family of growth factors as they all have an 
EGF-like domain. Nearly all are synthesized as transmembrane precursors, and mature 
soluble ligands are produced by extracellular cleavage by metalloproteases (reviewed in 
Harris et al. 2003). The ligands differ in their specificity. Some ligands bind exclusively to 
one member of the ErbB family, whereas others can bind and activate more than one 
receptor (as summarized in Figure 1). Despite the large number of ligands identified for 
EGFR, ErbB3 and ErbB4, no ligand has been identified for ErbB2 (Olayioye et al. 2000). 
The extracellular domain of ErbB2 has a tethered structure which makes ligand binding 
difficult (reviewed in Garrett et al. 2003). It therefore seems that ErbB2 functions primarily 
as a co-receptor, and it is considered the preferred dimerization partner for the other ErbB 
proteins, as the tethered structure causes the dimerization loop to be constitutively exposed 
(Garrett et al. 2003).   
 
 
 
 
Figure 1. Members of the ErbB protein family and their ligands. EGFR, ErbB3 and ErbB4 bind a 
distinct set of ligands, including EGF, Transforming Growth Factor  (TGF), Amphiregulin (ARG), 
Betacellulin (BTC), Heparin-binding EGF (HBEGF), Epiregulin (ERG) and Neuregulins (NRG1-4). 
ErbB2 does not bind any ligand. Reprinted from Advances in Protein Chemistry, Vol 68,  Daniel J. 
Leahy, Structure and Function of the Epidermal Growth Factor (EGF/ErbB) Family of Receptors, 1-27, 
©2004, with permission from Elsevier. The figure legend is modified. 
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1.1.1 EGFR 
EGFR is the most extensively studied ErbB protein, and it was also the first member of this 
family to be discovered (Carpenter et al. 1978). The EGFR is a 175-kDa protein, and like 
the other ErbB-proteins, it is highly glycosylated with 9 out of 11 potential glycosylation 
sites utilized (Zhen et al. 2003). The glycosylation seems to be essential for translocation of 
EGFR to the cell surface (Slieker et al. 1986). The EGFR ligands bind to the extracellular 
domain which is comprised of four subdomains (I-IV). These subdomains are arranged as 
tandem repeats of two different types of domains. Subdomains I and III (also named L1 and 
L2) are two large homologous domains shown to be responsible for ligand binding, while 
subdomains II and IV are cysteine-rich subdomains responsible for dimerization (reviewed 
in Burgess et al. 2003). One single -helix comprises the transmembrane domain (Rigby et 
al. 1998). The cytoplasmic domain can be divided in three regions: the juxtamembrane 
domain, the tyrosin kinase domain and the C-terminal regulatory region (see Figure 2 for an 
overview). The juxtamembrane domain is considered to have a regulatory role in receptor 
down-regulation (Fuller et al. 2008). The kinase domain of EGFR is structurally similar to 
other tyrosine kinases, and it catalyzes the transfer of phosphate from ATP to acceptor 
tyrosines in other substrates as well as in the C-terminal tail of the receptor itself (a process 
termed autophosphorylation) (Honegger et al. 1989; Honegger et al. 1990). The C-terminal 
regulatory region contains several tyrosine, serine 
and threonine residues which can be 
phosphorylated and thereby play important roles 
in signal transduction (Olayioye et al. 2000; 
Yarden and Sliwkowski 2001).       
 
 
 
 
Figure 2. Schematic overview of the domain 
organization in EGFR. the domains are referred to 
using the I, II, III, IV nomenclature. An alternative 
nomenclature using domain names L1, CR1, L2, CR2 is 
also used in the literature. Numbers refer to the amino 
acid residues in EGFR. Reprinted from Molecular Cell, 
Vol 12, Burgess et al., An Open and Shut Case? Recent 
Insight into the Activation of EGF/ErbB Receptors, 541-
52, ©2003 with permission from Elsevier. The figure 
legend is modified. 
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1.1.2 EGFR activation and signal transduction 
In the absence of ligand, EGFR proteins exist in both monomeric and dimeric forms. 
However, upon ligand binding, the EGFR is stabilized in an active state with the 
dimerization loop exposed, thus increasing the formation of and stability of EGFR dimers 
(reviewed in Jorissen et al. 2003). Binding of ligand and receptor dimerization triggers the 
tyrosine kinase activity of EGFR, leading to phosphorylation of tyrosine residues in the 
receptor itself, in the dimerization partner, and in other effector molecules. The C-terminal 
tail of the receptor contains five tyrosines that upon phosphorylation serve as docking sites 
for src homology (SH) 2 or phosphotyrosine binding (PTB) domains of intracellular signal 
transducers or adaptor proteins (reviewed in Singh and Harris 2005). This recruitment leads 
to activation of different signaling pathways (see Figure 3 for an overview).  
Figure 3. The diversity of the signaling network activated by ligand-dependent activation of the 
EGFR. Ligand binding induces receptor homo- or hetero-dimerization resulting in tyrosine phosphorylation 
of the cytoplasmic tail. The selective activation of well characterized signaling transduction pathways 
depends on the various arrangements of ligand-receptor engagement, tyrosine phosphorylation, and 
subsequent receptor dimerization combinations as well the stage and context of cell type and growth. 
Reprinted from Cellular Signalling, Vol 17, Sing, A.B. and Harris, R.C., Autocrine, paracrine and juxtacrine 
signalling by EGFR ligands, 1183-93, ©2005, with permission from Elsevier. 
The signaling network originating from EGFR is complex and involves protein-protein 
interactions, protein-lipid interactions, phosphorylation, dephosphorylation, ubiquitination, 
and second messengers. This signaling network comprises several different signaling 
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pathways which involves Phospholipase C  (PLC-), Ras and Mitogen-activated protein 
kinases (ras-MAPKs), Multiple signal transducer and activator of transcription (STAT) 
isoforms, heterotrimeric G-proteins, Phosphatidylinositol 3-kinase (PI3K), Phospholipase D 
(PLD) and the proto-oncogene cytoplasmic tyrosine kinase Src (reviewed in Singh and 
Harris 2005). The biological outcome of EGFR signaling is highly diverse, ranging from 
cell division, migration, adhesion, and differentiation to apoptosis (reviewed in Yarden and 
Sliwkowski 2001), and it is determined both by the identity of the ligand and by the EGFR 
dimerization partner (Olayioye et al. 2000).  
 
1.1.3 Ubiquitination of EGFR 
As described above, the EGFR is covalently modified by phosphorylation upon activation 
with EGF. Another post-translational modification of EGFR induced by binding of EGF is 
ubiquitination. Ubiquitination refers to the covalent attachment of ubiquitin to a lysine 
residue in a target protein (reviewed in Pickart 2001). Ubiquitin is a highly conserved small 
polypeptide consisting of 76 amino acids which is ubiquitously expressed in all eukaryotes 
(thus, giving rise to its name). Ubiquitination of proteins can be induced by a broad range of 
stimuli and signaling events. This highly regulated mechanism involves three enzymes; a 
ubiquitin-activating enzyme (E1), a ubiquitin-conjugating enzyme (E2) and a ubiquitin 
ligase (E3) (see Figure 4 and figure text). If one single ubiquitin molecule is conjugated to 
the target protein, the modification is called monoubiquitination. Alternatively, several 
ubiquitin molecules can each be conjugated to different lysine residues within the target 
protein, resulting in multiple monoubiquitination. Ubiquitin itself contains several lysine 
residues and can thus also be substrate for ubiquitination, forming polyubiquitin chains, a 
process denoted polyubiquitination (reviewed in Haglund and Dikic 2005). In the case of 
polyubiquitination, different linkages between the ubiquitin monomers exist, defined by 
which lysine residue in the ubiquitin monomer that is the substrate for further 
ubiquitination. Lysine-48 linkage is mainly a signal for targeting proteins to the proteasome 
for degradation, whereas lysine-63 linkage is involved in DNA-repair, inflammatory 
responses, ribosomal protein synthesis and in the endocytic pathway (which will be 
discussed in more detail later) (reviewed in Mukhopadhyay and Riezman 2007).  
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Figure 4. Protein ubiquitination. (a) The ubiquitination reaction consists of three steps: the single 
ubiquitin activating enzyme or E1 mediates the ATP-dependent activation of the C-terminal glycine of 
ubiquitin, which is conjugated to an active site cysteine through a thiol-ester linkage. Ubiquitin is then 
transferred to a cysteine in the active site of one of several ubiquitin-conjugating enzymes or E2s. Although 
some E2s can ubiquitinate substrates directly, in most cases an E3 ubiquitin ligase is required, and they 
provide the specificity of the ubiquitination reaction by binding substrates. There are multiple E3 ubiquitin 
ligases, with two major types that mediate ubiquitination in a distinct manner: HECT domain-containing 
E3s, such as Nedd4, form a thiol–ester linkage with a ubiquitin transferred from the E2, which is 
subsequently conjugated to the substrate. RING finger E3s, including Cbl, function as adaptors that bind 
both E2 enzymes and substrates to coordinate substrate ubiquitination. Both reactions result in the 
formation of an isopeptide bond between the C-terminal glycine of ubiquitin and the -amino group of a 
lysine residue within the substrate. Several types of substrate modification by ubiquitin can ensue (b) 
conjugation with one ubiquitin moiety (monoubiquitination), conjugation with multiple ubiquitin monomers 
(multiubiquitination) or the formation of a ubiquitin chain branched at internal lysines within ubiquitin 
(polyubiquitination). Reprinted by permission from Macmillan Publishers Ltd: Oncogene, 2004; 23:2057-
70, ©2008.  
In 1995, Galcheva-Gargova and coworkers discovered that EGFR from cells incubated with 
EGF migrated as a smear of differently increased molecular weight after SDS 
Polyacrylamide gel electrophoresis, and that this smear represented ubiquitinated EGFR 
(Galcheva-Gargova et al. 1995). The EGF-induced ubiquitination was additionally found to 
be dependent on the activity of EGFR’s kinase domain (Galcheva-Gargova et al. 1995). It is 
well established that the EGF-induced ubiquitination of EGFR is mediated by the ubiquitin 
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ligase Cbl (Joazeiro et al. 1999; Levkowitz et al. 1999; Lill et al. 2000; Thien and Langdon 
2001). Cbl binds to EGFR upon ligand-induced phosphorylation of EGFR, either directly 
via its PTB domain to phosphotyrosine 1045 or indirectly through Grb2 (Levkowitz et al. 
1999; Waterman et al. 2002). Both direct and indirect association of Cbl with EGFR is 
reported to result in ubiquitination of EGFR (Levkowitz et al. 1999; Waterman et al. 2002). 
Initially, EGFR was reported to be polyubiquitinated (Galcheva-Gargova et al. 1995). 
However, a few years later, it was reported that EGFR was multiply monoubiquitinated 
rather than polyubiquitinated (Haglund et al. 2003; Mosesson et al. 2003). More recently, 
mass spectrometry studies revealed that upon EGFR activation, the receptor was in fact 
polyubiquitinated as well as monoubiquitinated, and that the majority of the ubiquitin 
moieties were attached to lysine residues within the kinase domain (Huang et al. 2006). 
Ubiquitination of EGFR mediates sorting to and degradation in lysosomes (reviewed in 
Miranda and Sorkin 2007). It was initially proposed that the ubiquitination of EGFR takes 
place in endosomes, after EGFR internalization from the plasma membrane (Levkowitz et 
al. 1998). It was however later demonstrated by our group and others that ubiquitination of 
EGFR also occurs in cells where the internalization step is blocked in different ways (Stang 
et al. 2000; de Melker et al. 2001; Longva et al. 2002). Additionally, it is clear that the 
ubiquitin ligase Cbl is recruited to EGFR localized at the plasma membrane (de Melker et 
al. 2001; Longva et al. 2002). Taken together, these results reveal that ligand-induced 
ubiquitination of EGFR is a process taking place at the plasma membrane prior to 
internalization.  
1.2 ENDOCYTOSIS
Macromolecules are taken into cells by the process called endocytosis. Endocytosis is the 
internalization of extracellular materials together with a part of the plasma membrane. 
Endocytosis can be divided into two broad categories: phagocytosis and pinocytosis (also 
termed “cell eating” and “cell drinking”, respectively). Phagocytosis is the uptake of large 
particles, e.g. bacteria, and it is mostly performed by specialized cells, like macrophages, 
monocytes and neutrophils. Pinocytosis refers to fluid-phase uptake, and can further be 
divided into macropinocytosis, clathrin-mediated endocytosis, caveolae-mediated 
endocytosis and caveolae- and clathrin-independent endocytosis (Figure 5) (reviewed in 
Conner and Schmid 2003b). Different classifications exist, defined by requirements for 
different factors in endocytosis. In this thesis, the classification from Conner and Schmid is 
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used (Conner and Schmid 2003b). At present, the best characterized endocytic pathway is 
the one mediated by clathrin. 
 
 
Figure 5. Multiple portals of entry into the cell. Large particles are taken up by phagocytosis, while 
fluids and smaller particles are taken up by pinocytosis. This can occur either through macropinocytosis or 
by formation of vesicles by invagination of the plasma membrane. The major route of endocytosis is 
clathrin-mediated endocytosis, where a clathrin-coat encloses the forming vesicle. Endocytosis can also 
occur independently of clathrin. In caveolin-mediated endocytosis the uptake is via vesicles enriched in 
caveolin. There is also evidence for other routes of internalization independent of both clathrin and 
caveolin. At least two different pathways have been described, one dependent on dynamin, and one 
independent on dynamin. Reprinted by permission from Macmillan Publishers Ltd: Nature, 2003; 422:37-
44, ©2008. The figure legend is modified. 
1.2.1 Clathrin-mediated endocytosis 
Clathrin-mediated endocytosis occurs in all nucleated cells, either constitutively or in 
response to certain stimuli, and is an important mechanism for entry of nutrients and 
membrane-bound receptors and their ligands into cells. Examples of such receptors and 
ligands are transferrin (Tf) and the Tf receptor (TfR) and low-density lipoprotein (LDL) and 
its receptor, the LDLR (reviewed in Conner and Schmid 2003b). Clathrin-mediated 
endocytosis is characterized by the formation of a protein coat mainly consisting of clathrin 
on the cytosolic side of the plasma membrane. Invagination of the plasma membrane in the 
clathrin-coated area generates clathrin-coated pits. Moreover, clathrin-mediated endocytosis 
involves the concentration of transmembrane receptors and their ligands in clathrin-coated 
pits, further invagination of the plasma membrane, and eventually pinching off from the 
membrane to form clathrin-coated vesicles inside the cell (Conner and Schmid 2003b). The 
endocytic pathway is named after the definitive requirement for clathrin, although a number 
of different proteins are also reported to be involved and required in the process. Such 
accessory endocytic proteins include among others the clathrin adaptor complex 2 (AP-2) 
and dynamin (Figure 6), which will be described in more detail below. These proteins, and 
others, are recruited to areas of the plasma membrane enriched in phosphatidylinositol 4,5-
8 
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P2 (PIP2), followed by concentration of the endocytic cargo in clathrin-coated pits (Ehrlich 
et al. 2004).  
1.2.1.1 Clathrin 
As mentioned, clathrin is the major component of the endocytic clathrin coat. In the clathrin 
coat, it exists as a trimeric protein complex consisting of three heavy chains and three light 
chains. The three heavy chains comprise a three-legged structure, a triskelion. The triskelion 
in turn oligomerizes into a cage-like lattice at the plasma membrane, thereby forming the 
protein coat (reviewed in Kirchhausen 2000; Conner and Schmid 2003b). It has been 
reported that clathrin is essential for the invagination of coated pits (Hinrichsen et al. 2006). 
Clathrin has no identified lipid-binding motifs, and is thus dependent on other proteins, 
often referred to as adaptor proteins, to associate with the lipid bilayer in the plasma 
membrane (reviewed in Kirchhausen 2000; Sorkin 2004). It is well documented that the 
clathrin adaptor complex AP-2 has such a function (reviewed in Robinson and Bonifacino 
2001; Conner and Schmid 2003b; Traub 2005).  
 
 
 
Figure 6. Core components of clathrin-coated pits. Clathrin triskelions, composed of three clathrin 
heavy chains (CHC) and three tightly associated light chains (CLC), assemble into a polygonal lattice, 
which helps to deform the overlying plasma membrane into a coated pit. Heterotetrameric AP-2 complexes 
are targeted to the plasma membrane by the -adaptin subunits, where they mediate clathrin assembly 
through the 2-subunit, and interact directly with sorting motifs on cargo molecules through their μ2 
subunits. Dynamin is a multidomain GTPase that is recruited to clathrin-coated pits, where it can assemble 
into a spiral or 'collar' to mediate or monitor membrane fission and the release of clathrin-coated vesicles. 
Reprinted by permission from Macmillan Publishers Ltd: Nature, 2003; 422:37-44, ©2008. The figure 
legend is modified. 
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1.2.1.2 AP-2 
Four structurally related adaptor complexes (AP-1 to AP-4) have been described, and they 
are reported to be involved in coat assembly at different subcellular sites (reviewed in 
Robinson and Bonifacino 2001). Of these four, only AP-2 is involved in clathrin-coat 
assembly at the plasma membrane. AP-2 is a heterotetrameric complex consisting of two 
large core subunits, the - and 2-adaptins, a medium subunit, the μ2, and a small subunit, 
the 2 (see Figure 6 for an overview) (Conner and Schmid 2003b). The core of the -
subunit binds to PIP2 in the plasma membrane (Beck and Keen 1991), and the -appendage 
of the -subunit is thought to serve as an interacting hub for accessory endocytic proteins 
(Praefcke et al. 2004). The 2-subunit binds to clathrin, and the μ2-subunit is considered to 
be the cargo selection unit of the complex, binding to sorting motifs in cargo molecules at 
the plasma membrane. Finally, the 2-subunit seems to have a role in stabilizing the AP-2 
complex (Conner and Schmid 2003b). The AP-2 complex is thought to be one of the key 
components of clathrin-mediated endocytosis. Consistent with this, it is demonstrated that 
depleting cells of AP-2 disrupts endocytosis of the TfR (Hinrichsen et al. 2003; Motley et al. 
2003). However, endocytosis of EGFR is reported to be less affected by AP-2 depletion 
(Hinrichsen et al. 2003; Motley et al. 2003; Huang et al. 2004; Johannessen et al. 2006), 
suggesting that AP-2 is not absolutely critical for clathrin-mediated endocytosis.  
1.2.1.3 Dynamin 
Dynamin is a large GTPase belonging to the dynamin superfamily of proteins. This family 
of proteins includes the classical dynamins, dynamin-related proteins and the guanylate-
binding proteins, all of which are classified according to their domain structure. The 
classical dynamins comprise dynamin1, which is mainly expressed in neuronal-tissue, 
dynamin2 which is ubiquitously expressed, and the brain- and testis-enriched dynamin3. All 
dynamins have identical domain architecture. They have a GTPase domain, a middle 
domain with no known function, a pleckstrin homology (PH) domain binding to PIP2, and a 
GTPase effector domain which functions as an internal GTPase activating protein domain. 
The C-terminal part of the proteins encloses a proline rich domain (PRD) that interacts with 
proteins containing SH3 domains (Figure 6) (reviewed in Praefcke and McMahon 2004; 
Kruchten and McNiven 2006). Dynamin was reported to be involved in endocytosis as early 
as 1991 by van der Bliek and Meyerowitz (van der Bliek and Meyerowitz 1991). It is 
proposed that the GTPase activity of dynamin is necessary for its function in endocytosis 
(Damke et al. 1994; Hill et al. 2001), but the exact mechanism of action is still debated. 
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Dynamin is proposed to function either directly as a “pinchcase” pinching off membrane 
invaginations, or as a regulator of other mechanochemical enzymes (reviewed in Conner 
and Schmid 2003b; Praefcke and McMahon 2004). Dynamin is not exclusively involved in 
clathrin-mediated endocytosis, it is also a required factor in several of the clathrin-
independent endocytic pathways. 
1.2.2 Clathrin-independent endocytosis 
Endocytosis can also occur clathrin-independently. clathrin-mediated endocytosis has for 
several years been considered as the main internalization route for plasma membrane 
localized proteins; however, the knowledge of clathrin-independent endocytic pathways is 
emerging, and a number of ‘new’ internalization routes have now been described.  
1.2.2.1 Macropinocytosis 
Macropinocytosis is a triggered process where the cells internalize large amounts of fluid 
and membrane. It is often induced by growth factors, and it is characterized by actin-driven 
membrane ruffling, formation of protrusions that collapse onto the plasma membrane, and 
formation of large endocytic vesicles called macropinosomes (Swanson and Watts 1995; 
Pelkmans and Helenius 2003).  
1.2.2.2 Caveolae-mediated endocytosis  
Caveolae are small flask-shaped invaginations of the plasma membrane present in many cell 
types, but enriched in endothelial cells. Caveolae lack a cytoplasmic coat but are 
characterized by the presence of the protein caveolin, which is inserted into the cytoplasmic 
leaflet of plasma membrane and stabilizes the membrane curvature (reviewed in Gong et al. 
2007). Caveolae are one type of rafts, which are specialized lipid microdomains of the 
plasma membrane enriched in sphingolipids, cholesterol and glycosyl phosphatidyl (GPI) -
anchored proteins (reviewed in Conner and Schmid 2003b; Mayor and Pagano 2007). 
Caveolae were initially reported to be relatively immobile structures of the plasma 
membrane (Thomsen et al. 2002), but it was later demonstrated that caveolae can internalize 
slowly to form caveosomes and that this process is dependent on dynamin and actin 
assembly (reviewed in Parton and Simons 2007). 
1.2.2.3 Caveolae- and clathrin-independent endocytosis 
Several endocytic pathways independent of both clathrin and caveolin are also described. 
Some of these internalization routes are based on lipid microdomains, exemplified by 
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internalization of interleukin-2 receptor and c cytokine receptor (Lamaze et al. 2001; 
Kirkham and Parton 2005; Sauvonnet et al. 2005). A flotillin-dependent endocytic pathway 
has recently been described (Glebov et al. 2006), and it has been proposed that flotillin 
displays structural functions during endocytosis similar to the role caveolin has in caveolae-
mediated endocytosis (Bauer and Pelkmans 2006; Gong et al. 2007). The requirement for 
dynamin varies among the clathrin and caveolin-independent endocytic pathways; receptor 
for interleukin-2 and the c cytokine receptor both are dependent on dynamin for 
internalization, whereas cholera toxin B and some GPI-anchored proteins can be 
internalized from lipid rafts independently of dynamin (reviewed in Kirkham and Parton 
2005; Gong et al. 2007). A new classification of clathrin-independent endocytosis was 
recently proposed, defined by the requirement for dynamin and further subdivided into 
pathways characterized by the GTPase involved (Mayor and Pagano 2007). It seems that 
cargo can utilize different endocytic pathways depending on cell line and accessible adaptor 
proteins (Sandvig and van Deurs 2002). The number of clathrin and caveolin-independent 
endocytic pathways and the molecules involved thus remain unclear at present.  
1.2.3 Ubiquitination as endocytic signal 
Ubiquitination of proteins was initially discovered to be a signal for proteasomal 
degradation of cytosolic proteins, but has later been implicated in a number of other cellular 
processes, including endocytosis. In 1996, Linda Hicke and coworkers identified 
ubiquitination as a signal for endocytosis in yeast, and demonstrated that one single 
ubiquitin molecule could be sufficient for mediating endocytosis (Hicke and Riezman 
1996). The requirement for ubiquitination has been demonstrated in endocytosis of certain 
plasma membrane proteins in yeast, for example Ste2p, a G-protein coupled receptor (Hicke 
and Riezman 1996), and the Fur4-encoded uracil permease (Galan et al. 1996; Galan and 
Haguenauer-Tsapis 1997).  
 
In mammalian cells, tyrosine-based and di-leucine motifs are well described signals for 
directing endocytosis of plasma membrane localized proteins (reviewed in Bonifacino and 
Traub 2003). These motifs serve as recognition signals for cargo selecting adaptor proteins 
(i.e. AP-2 and disabled 2) during endocytosis. The TfR and LDLR are both internalized 
constitutively via clathrin-mediated endocytosis, and both harbor tyrosine based motifs that 
are recognized by AP-2 (Chen et al. 1990; Jing et al. 1990; Boll et al. 2002; reviewed in 
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Bonifacino and Traub 2003). In addition to these internalization motifs, ubiquitination has 
later been identified as an endocytic signal in higher eukaryotes, as ubiquitination of certain 
plasma membrane proteins appears to be sufficient for internalization. After fusing one 
single ubiquitin molecule to the cytoplasmic part of a truncated form of EGFR, the EGFR-
ubiquitin chimera was constitutively endocytosed (Haglund et al. 2003). It has also been 
shown that fusing ubiquitin moieties to the plasma membrane localized protein CD4, 
induces its endocytosis (Barriere et al. 2006). Furthermore, endocytosis of the growth 
hormone (GH) receptor (GHR) has been shown to depend on an intact ubiquitination 
machinery, although the direct requirement for ubiquitination of the receptor itself could not 
be demonstrated (Strous et al. 1996; Sachse et al. 2001; van Kerkhof et al. 2007). In 
contrast, it has been demonstrated that ubiquitination of the receptors for nerve growth 
factor, for leptin and for dopamine is instrumental in initial steps of endocytosis of these 
receptors (Geetha et al. 2005; Belouzard and Rouille 2006; Miranda et al. 2007). In order to 
function as endocytic signal in clathrin-mediated endocytosis, ubiquitin has to be recognized 
by proteins associated with the clathrin-coated pit. Interestingly, several proteins involved in 
clathrin-mediated endocytosis (e.g. epsin and eps15, which will be discussed later) indeed 
possess ubiquitin interacting motifs (UIMs) (Hofmann and Falquet 2001). Ubiquitination 
can also direct proteins from the trans-Golgi network to endosomes (Piper and Luzio 2007) 
and can additionally serve as signal for sorting of proteins at late endosomes.  
1.2.4 Endocytic down-regulation of EGFR 
After ligand binding and activation, EGFR is rapidly internalized. Endocytosis of EGFR is a 
common model system for studying receptor-mediated endocytosis from clathrin-coated 
pits. The requirement for different adaptor proteins and accessory endocytic proteins are, 
however, still disputed, and the exact mechanism for endocytic down-regulation remains 
unclear. There is general agreement that EGFR can be internalized through clathrin-coated 
pits after ligand binding (Carpentier et al. 1982; Hanover et al. 1984). It has also been 
suggested that endocytosis of EGFR can occur independently of clathrin (Hinrichsen et al. 
2003) and that EGFR is enriched in and can be internalized from caveolae at high 
concentrations of ligand (Sigismund et al. 2005). More recently, it was, however, 
demonstrated that the main internalization route for EGFR is clathrin-mediated endocytosis, 
both at high and low concentrations of EGF and that EGF did not induce mobilization of 
caveolae (Kazazic et al. 2006). In addition to clathrin, the internalization of EGFR is 
13 
INTRODUCTION 
 
controlled by interaction of EGFR with several different proteins, such as Grb2, Cbl, Eps15, 
and epsin.  
1.2.4.1 Grb2 
Grb2 consists of an SH2 domain flanked by two SH3 domains. It binds via its SH2 domain 
to phosphotyrosines 1086 or 1068 of EGFR upon activation of EGFR. It is well established 
that Grb2 is important in signaling from EGFR by recruiting important proteins involved in 
activation of signaling cascades via its SH3 domains. One example of such a protein is Son 
of sevenless (Sos) (Jorissen et al. 2003). Additionally, Grb2 has been shown to be critical 
for endocytosis of EGFR, since mutation of the two Grb2-binding sites in EGFR as well as 
depletion of Grb2 by RNA interference (RNAi) effectively hinder EGFR internalization 
(Sorkina et al. 2002; Jiang et al. 2003). In addition, it has been proposed that Grb2 plays an 
important role in recruiting the activated EGFR to clathrin-coated pits (Jiang et al. 2003). 
Furthermore, Grb2 has been suggested to recruit the ubiquitin ligase Cbl to EGFR upon 
activation. The Grb2 SH3 domain associates with proline rich sequences in Cbl (Meisner et 
al. 1995) and thereby guides Cbl to EGFR (Huang and Sorkin 2005). Consistently, a mutant 
form of Grb2 not able to bind Cbl was demonstrated to inhibit the internalization of EGFR 
(Jiang et al. 2003). 
1.2.4.2 Cbl 
Cbl is a protein which functions as a negative regulator of signaling from tyrosine kinases, 
and it is involved in endocytic down-regulation of EGFR. Three different mammalian forms 
of Cbl have been identified; c-Cbl, Cbl-b and Cbl-3 (also called Cbl-c). All these three 
forms are reported to interact with EGFR in an EGF-dependent manner (Thien and Langdon 
2001; Thien and Langdon 2005; Swaminathan and Tsygankov 2006). The Cbl proteins have 
several highly conserved domains including the N-terminal PTB domain recognizing 
phosphorylated tyrosines on RTKs and the centrally located RING-finger domain recruiting 
ubiquitin conjugating enzymes. Additionally, c-Cbl and Cbl-b contain several tyrosine 
phosphorylation sites as well as proline rich sequences that can bind to SH3-domain 
containing proteins (Ryan et al. 2006). These characteristics define the Cbl-proteins as 
multifunctional proteins capable of acting both as ubiquitin ligases and as adaptor proteins. 
As previously mentioned, Cbl interacts with activated EGFR in two ways; directly via the 
PTB domain and indirectly through Grb2 (Figure 7). Both direct and indirect association of 
Cbl with EGFR is known to mediate ubiquitination of EGFR (Waterman et al. 2002). It is, 
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however, reported that both direct and indirect association of Cbl with EGFR are required 
for efficient EGFR ubiquitination (Lill et al. 2000). It has furthermore been proposed that 
the direct EGFR-Cbl interaction is necessary for degradation of EGFR in lysosomes (Jiang 
et al. 2003; Grovdal et al. 2004), while the indirect binding of Cbl through Grb2 mediates 
recruitment of activated EGFR to clathrin-coated pits prior to internalization (Huang and 
Sorkin 2005). Although it seems clear that Cbl positively regulates endocytosis of EGFR, it 
is currently an open question whether Cbl regulates endocytosis of EGFR as a ubiquitin 
ligase or as an adaptor protein.  
 
 
 
Figure 7. Binding of c-Cbl to EGFR. 
Upon ligand binding, c-Cbl is recruited to 
the plasma membrane where it associates 
with, and ubiquitinates, the activated 
EGFR prior to receptor internalization. c-
Cbl binds to the activated EGFR both 
directly and indirectly. Direct binding is 
mediated through phosphorylated tyrosine 
residue 1045 on the EGFR whereas 
indirect binding is mediated through the 
adapter protein Grb2, which binds to 
phosphorylated tyrosine residues 1086 and 
1068 on the receptor. Reprinted from 
Cellular Signalling, Vol 19, Zandi et al, 
Mechanisms for oncogenic activation of 
the epidermal growth factor receptor, 
2013-23, ©2007, with permission from 
Elsevier. The figure legend is modified. 
1.2.4.3 Eps15 
Eps15 was originally discovered as a substrate for the EGFR kinase, but has later been 
implicated in clathrin-mediated endocytosis, primarily by binding to AP-2 (Tebar et al. 
1996). In the N-terminal part, Eps15 harbors three Eps15 homology (EH) domains, which 
are domains often found in proteins associated with endocytosis and vesicle transport. 
Eps15 also contains a coiled-coil domain, DPF repeats and UIMs (Salcini et al. 1999). Upon 
EGFR activation, Eps15 is recruited to clathrin-coated pits at the plasma membrane (Torrisi 
et al. 1999; Stang et al. 2004), and the EH-domains of Eps15 were demonstrated to be 
required for this relocalization (Benmerah et al. 1999). The relocalization of Eps15 to 
clathrin-coated pits upon activation of EGFR might indicate that Eps15 is involved in 
endocytosis of EGFR, but this has to date not been confirmed. Some research groups have 
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been able to demonstrate that RNAi-mediated knock down of Eps15 negatively impacts on 
internalization of EGFR (Huang et al. 2004; Fallon et al. 2006), whereas others have 
reported no effect on EGFR endocytosis upon Eps15 knock down (Sigismund et al. 2005). 
The involvement of Eps15 in endocytic down-regulation of EGFR is thus still unclear. 
Concerning that a) Eps15 harbors two UIMs which binds to ubiquitinated proteins, b) 
ubiquitination is suggested to be involved in recruiting activated EGFR to clathrin-coated 
pits (Stang et al. 2004), c) EGFR is ubiquitinated at the plasma membrane in an EGF-
dependent manner, and d) Eps15 localizes to clathrin-coated pits in response to EGF, one 
could speculate that Eps15 might function as an adaptor protein for sorting of ubiquitinated 
cargo, such as EGFR, to clathrin-coated pits prior to endocytosis. 
1.2.4.4 Epsin 
Another UIM-containing protein suggested to be involved in endocytosis of EGFR is epsin. 
At present, five human epsin homologs have been described (hEpsin, hEpsin1, hEpsin2a, 
hEpsin2b and hEpsin3) (Sugiyama et al. 2005). The N-terminal part of the protein is highly 
conserved among the different epsin family members, and it is denoted the ENTH-domain 
(epsin N-terminal homology domain). The ENTH-domain targets epsin to the plasma 
membrane by binding to PIP2, and this interaction has been demonstrated to be necessary 
for EGFR endocytosis (Itoh et al. 2001). Following the ENTH-domain, the epsins contain 
tandem UIMs that can interact with ubiquitinated proteins (Chen and De Camilli 2005; 
Hawryluk et al. 2006). The central and C-terminal parts of epsins contain motifs that bind to 
clathrin, AP-2 and EH-domain-containing proteins such as Eps15 (Horvath et al. 2007). 
Epsin has been shown to be involved in formation or stabilization of membrane curvature 
(Ford et al. 2002; Ritter and McPherson 2006) and is also thought to serve as an adaptor 
protein in clathrin-mediated endocytosis (Horvath et al. 2007). Additionally, interaction of 
epsin with EGFR has been reported (Sigismund et al. 2005). This interaction has been 
characterized in paper III.  
1.2.4.5 Intracellular sorting of EGFR 
Clathrin-coated pits containing activated EGFR bud into the cell and form clathrin-coated 
vesicles, a process involving dynamin and the actin cytoskeleton. The clathrin-coated 
vesicles are then uncoated. The uncoated vesicles and their content mature into – or fuse 
with – early endosomes. Membrane fusion generating early endosomes is mediated by 
Rab5, early endosome antigen 1 (EEA1) and SNAREs. Moreover, the Trans-Golgi network 
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(TGN) contributes to the maturation of endosomes by providing lysosomal hydrolases (for 
review see Maxfield and McGraw 2004). In early endosomes, also termed sorting 
endosomes, the internalized receptors are sorted to distinct microdomains, for recycling 
back to the plasma membrane, for transport to the TGN or for lysosomal degradation. In 
early endosomes the environment is acidic due to proton pumps in the membrane. The low 
pH causes some of the receptor-bound ligands to dissociate from their receptor. This is the 
case if Transforming growth factor alpha (TGF) is bound to EGFR. TGF is released from 
EGFR, and the EGFR then enters early endosomal tubules and is recycled back to the 
plasma membrane. In contrast, the EGFR-EGF complex remains stable also at the low 
endosomal pH, and EGFR and EGF are sorted as a complex to intraluminal vesicles by 
inward budding of the limiting membrane of the endosome (Longva et al. 2002) (Figure 8). 
Formation of inner vesicles in endosomes generates the endosomal structures referred to as 
multivesicular bodies (MVBs). MVBs finally fuse with lysosomes, where both EGFR and 
EGF are degraded by acid hydrolases (Dunn et al. 1986; Futter et al. 1996; Raiborg et al. 
2003).  
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Trafficking of EGFR. The EGFR is 
internalized from clathrin-coated pits. The 
forming vesicles fuse with -or mature into- 
endosomes. In the sorting endosome, the 
receptors that are to be recycled are transferred 
to recycling endosomes while the receptors that 
are to be degraded are sorted to inner vesicles 
of a multi-vesicular body (MVB), and are 
eventually degraded in lysosomes. (The figure 
is from Breen 2008, reprinted with permission). 
 
Ubiquitination is the best characterized signal for sorting receptors into MVBs. For EGFR, 
it is well established that Cbl-mediated ubiquitination is a prerequisite for translocation to 
inner vesicles of MVBs. Moreover, it is the direct binding of Cbl to phosphotyrosine 1045 
of EGFR that is required for sorting to MVBs and thus receptor degradation (Grovdal et al. 
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2004). EGFR is sorted to inner vesicles of MVBs by sequential interaction with the four 
sorting protein complexes named ESCRT-0 to ESCRT-III (Endosomal Sorting Complexes 
Required for Transport). ESCRT-0 is a protein complex consisting of two proteins 
possessing one UIM each, the Hepathocyte growth factor regulated tyrosine kinase substrate 
(Hrs) and the Signal-transducing adaptor molecule (STAM). The ESCRT-0 protein complex 
seems to be essential for the initial sorting of ubiquitinated cargo at the endosomal 
membrane (Williams and Urbe 2007). Eps15 is not included in the ESCRT-0 complex. 
However, a fraction of Eps15 is also localized to endosomes and is reported to bind to Hrs. 
Interestingly, Eps15b, a novel isoform of Eps15, was recently described to be involved in 
sorting of EGFR for degradation (Roxrud et al. 2008). Downstream of binding ESCRT-0, 
ubiquitinated cargo is handed over to ESCRT-I, -II and III, respectively, before transport to 
inner vesicles of the MVBs and degradation (Raiborg et al. 2003; Piper and Luzio 2007; 
Williams and Urbe 2007). In the case of EGFR, it is reported that depletion of key 
components of all the four ESCRT-complexes by RNAi each strongly inhibits degradation 
of EGFR (Raiborg et al. 2008).  
1.3 EGFR IN CANCER
Cell division and reduced apoptosis are among the biological outputs of signaling from 
EGFR. Attenuation of EGFR signaling by endocytic down-regulation is important in 
controlling these processes. Thus, dysregulation of endocytosis and intracellular trafficking 
can lead to increased and uncontrolled cell proliferation and lower rate of apoptosis, both 
characteristics associated with cancer progression. EGFR was the first cell surface receptor 
reported to be directly linked to cancer (Todaro et al. 1976). Since then, the involvement of 
EGFR, as well as the other ErbB proteins in cancer, has been extensively studied (reviewed 
in Gschwind et al. 2004; Ciardiello and Tortora 2008). Overexpression of both EGFR and 
its ligands was demonstrated in various cancer forms, including brain malignancies and non-
small cell lung cancers (reviewed in Gullick 1991) and is often associated with poor 
prognosis (Holbro et al. 2003; Zandi et al. 2007). A number of mutations in the EGFR gene 
have been observed in various tumors, most common are deletions in the extracellular 
domain. These deletions are often associated with reduced ligand-induced down-regulation 
of EGFR, leading to sustained signaling (reviewed in Zandi et al. 2007). The EGFRvIII is 
the best characterized mutant form of EGFR. The EGFRvIII has a large extracellular 
deletion, rendering it incapable of ligand binding, but having a constitutively active kinase 
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domain (reviewed in Kuan et al. 2001). It has recently been demonstrated that the 
constitutively active EGFRvIII is less effectively ubiquitinated, and because of impaired 
internalization and increased recycling, this receptor escapes down-regulation (Grandal et 
al. 2007).  
 
Because of its role in tumor progression, the EGFR has been extensively studied. The EGFR 
is targeted in cancer treatment by two major strategies, by using antibodies binding to the 
extracellular domain of EGFR and/or inhibitors of EGFR’s kinase activity (Zandi et al. 
2007). It could also be of future interest to target EGFR in cancer treatment by altering its 
endocytic down-regulation. 
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2 AIMS OF THE STUDY 
The main focus of the work presented in this thesis has been to gain more insight into the 
molecular mechanisms controlling the initial steps of endocytic down-regulation of the 
EGFR. The importance of ubiquitination in endocytosis of EGFR has been a matter of 
debate, but the fact that the ubiquitin ligase Cbl is instrumental in endocytosis of EGFR is 
now well documented. It is still discussed whether Cbl functions as a ubiquitin ligase or as 
an adaptor protein in this process. A main aim has therefore been to investigate how Cbl-
mediated ubiquitination affects endocytosis of EGFR, with different subgoals: 
 
o In Paper I we wanted to use the Cbl-binding protein TULA (T-cell ubiquitin ligand) 
as a tool to inhibit EGF-induced ubiquitination of EGFR, and further to investigate 
how this would affect endocytosis of EGFR  
 
o In Paper II the aim was to study the role of Grb2 and Cbl-mediated ubiquitination in 
endocytosis and EGF-induced recruitment of EGFR to coated-pits 
 
o In Paper III we wanted to characterize the described interaction of EGFR and epsin 
1, and to investigate whether epsin 1 could function as an endocytic adaptor protein 
recruiting ubiquitinated EGFR to clathrin-coated pits 
 
o One of the aims in Paper IV was to characterize the role of the ubiquitin ligase Cbl 
in endocytosis of EGFR and in recruitment of activated EGFR into clathrin-coated 
pits. Another goal was to find out whether ubiquitination as such could function as a 
signal for EGFR endocytosis.   
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3 SUMMARY OF PAPERS 
3.1 PAPER I
The Cbl-binding protein TULA inhibits dynamin-dependent endocytosis. Vibeke Bertelsen,
Kamilla Breen, Kirsten Sandvig, Espen Stang, and Inger Helene Madshus.  
 
In this paper we studied how overexpression of TULA, a Cbl- and ubiquitin binding protein, 
affected endocytosis in HeLa cells. We confirmed that overexpression of TULA inhibited 
both ubiquitination and endocytosis of EGFR, as previously reported. Surprisingly, the 
endocytosis of Tf receptor, LDL receptor, Major histocompatibility complex class I (MHC-
I), and CD59, all endocytosed dynamin-dependently, was also strongly inhibited upon 
overexpression of TULA. In contrast, endocytosis of the plant toxin ricin, which uses 
dynamin-independent endocytic pathways for internalization, was not affected by TULA 
overexpression. By confocal microscopy and co-immunoprecipiation experiments, we found 
that TULA colocalized and interacted with dynamin. We therefore proposed that the SH3-
domain of TULA can interact with proline rich sequences in dynamin, and that 
overexpression of TULA inhibited dynamin-dependent endocytic pathways by functionally 
sequestering dynamin. Consistent with this, we showed that the TULA-induced inhibition of 
endocytosis could be counteracted by raising the cellular level of dynamin, or by disrupting
the TULA-dynamin interaction. This supported the idea that TULA inhibited these 
dynamin-dependent endocytic pathways by sequestering dynamin. However, overexpression 
of dynamin or mutation of the SH3-domain of TULA did not counteract the inhibitory effect 
TULA had on ubiquitination of EGFR, and consistently nor on endocytosis of EGF. We 
concluded that TULA inhibited clathrin-dependent and -independent endocytic pathways by 
functionally sequestering dynamin, and that there was a correlation between inhibition of 
ubiquitination and endocytosis of the EGFR. 
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3.2 PAPER II
Cbl-dependent ubiquitination is required for progression of EGF Receptors into clathrin-
coated pits. Espen Stang, Frøydis D. Blystad, Maja Kazazic, Vibeke Bertelsen, Tonje 
Brodahl, Camilla Raiborg, Harald Stenmark, and Inger Helene Madshus 
 
In this paper we studied the relevance of Grb2 and Cbl-induced ubiquitination in 
recruitment of activated EGFR into clathrin-coated pits. When the EGFR at the plasma 
membrane is activated by binding EGF, it also becomes ubiquitinated by the ubiquitin ligase 
Cbl. Immuno electron microscopy (Immuno-EM) studies demonstrated that when the EGFR 
was activated by EGF on ice, it translocated from smooth areas to clathrin coated areas at 
the plasma membrane. When ubiquitination of the EGFR was inhibited due to 
overexpression of a mutant form of Grb2 or overexpression of the Cbl-interacting protein 
hSpry2, the recruitment of EGFR into central parts of clathrin-coated pits was inhibited. 
Under such conditions, the EGFR localized predominantly to the rim of clathrin-coated pits. 
Additionally, Grb2, Cbl and hSpry2 were all found to localize to the rim of clathrin coated 
pits after incubation with EGF on ice, indicating that these proteins cooperate in recruitment 
of activated EGFR into the clathrin-coated pits. In addition to the correlation of inhibited 
ubiquitination and inhibited recruitment into clathrin-coated pits, we found that 
overexpression of a conjugation-defect ubiquitin similarly inhibited the ligand-induced 
recruitment of EGFR into clathrin-coated pits as well as the endocytosis of EGF. Although 
we cannot from these data conclude that ubiquitination of EGFR itself is a prerequisite for 
recruitment of EGFR into clathrin-coated pits, our data led us to propose that Cbl-induced 
ubiquitination is required to recruit EGFR into interior parts of clathrin-coated pits.  
3.3 PAPER III
Epsin recruits ubiquitinated EGF receptors into clathrin-coated pits. Maja Kazazic, Vibeke
Bertelsen, Ketil Winther Pedersen, Tram Thu Vuong, Michael Vibo Grandal, Marianne 
Skeie Rødland, Linton M. Traub, Espen Stang, and Inger Helene Madshus 
 
In this paper we studied the role of epsin as a ubiquitin-binding adaptor protein in 
endocytosis of EGFR. Epsin is a UIM-containing protein which is demonstrated to localize 
to clathrin-coated pits at the plasma membrane and also to associate with the EGFR. In this 
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work we showed by co-immunoprecipitation experiments that epsin interacted with 
ubiquitinated EGFR in a UIM-dependent manner. In cells where EGFR was less effectively 
ubiquitinated or when the UIMs of epsin 1 were mutated, the formation of an EGFR-epsin 
complex was reduced. Knocking down epsin 1 by RNAi resulted in a reduced 
internalization ratio of EGF, both at high and low EGF concentrations, whereas the 
internalization of Tf was unaffected. This indicated that epsin specifically was involved in 
endocytosis of EGFR and not in clathrin-mediated endocytosis in general. Immuno-EM 
studies confirmed the role of epsin 1 in clathrin-dependent endocytosis of EGFR; RNAi-
mediated knock down of epsin 1 interfered with the EGF-induced recruitment of the EGFR 
into clathrin-coated pits. When the cells were depleted of epsin 1, the recruitment of EGFR 
into central parts of clathrin-coated pits was strongly inhibited compared to in control cells. 
We therefore concluded that epsin 1 acts as an adaptor protein that recruits ubiquitinated 
EGFR into clathrin-coated pits prior to endocytosis.    
3.4 PAPER IV
Cbl and ubiquitination promote translocation of EGF Receptor into clathrin-coated pits. 
Vibeke Bertelsen, Malgorzata M. Sak, Kamilla Breen, Espen Stang, and Inger Helene 
Madshus.
 
In paper IV we further studied the relevance of Cbl and Cbl-induced ubiquitination for the 
recruitment of activated EGFR into clathrin-coated pits as well as whether ubiquitin in 
isolation could induce endocytosis of EGFR. By siRNA-mediated knock down of c-Cbl and 
Cbl-b, we found that the EGF-induced ubiquitination and endocytosis of EGFR were both 
inhibited. Moreover, we also found by using immuno-EM that by depleting the cells of c-
Cbl and Cbl-b, activated EGFR was less efficiently recruited to clathrin coated pits. We 
additionally found that the distribution of EGFR within coated pits was affected. In control 
cells, most of the clathrin-coated pit-associated EGFRs were found in interior parts of the 
pits. Contrastingly, in cells where c-Cbl and Cbl-b had been knocked down, clathrin-coated 
pit associated EGFRs predominantly localized to the rim of coated pits. We therefore 
suggested that consistent with our previous findings, Cbl-mediated ubiquitination facilitates 
endocytosis of EGFR by guiding EGFR into clathrin-coated pits prior to internalization. To 
address whether ubiquitin could function as an endocytosis signal for EGFR, we constructed 
an EGFR-ubiquitin chimera with 4 ubiquitins fused to the C-terminal tail of full-length 
SUMMARY OF PAPERS 
 
EGFR via a flexible linker (EGFR-Ub4). By confocal microscopy, we observed this 
chimeric protein in early endosomes in the absence of added EGF. The EGFR-Ub4 was 
internalized from the plasma membrane in a clathrin-dependent manner without requirement 
for EGF or EGFR kinase activity and also without recruiting c-Cbl. This strongly indicates 
that ubiquitination of EGFR per se can mediate clathrin-dependent endocytosis of EGFR. 
We thus concluded that Cbl-mediated ubiquitination of EGFR facilitates clathrin-dependent 
endocytosis of the EGFR by guiding ubiquitinated EGFR into clathrin-coated pits.  
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4 METHODOLOGICAL CONSIDERATIONS 
Detailed descriptions of the methods used in this work are given in the papers. In 
general, all experiments included have been performed three times or more, and when 
statistics has been needed, standard deviation (SD) has been calculated. The following 
section will discuss the advantages and limitations of some of the methods used.  
4.1 CELL LINES/EXPERIMENTAL CELL SYSTEMS
Different cell lines are used throughout this work: HeLa cells, Hep2-cells and Porcine 
Aortic Endothelial (PAE) cells. Most of the experiments are performed in the human 
cervical carcinoma cell line, HeLa. We have mainly used HeLa cells because they are 
easy to work with, they are easy to transfect, they express relatively high levels of 
EGFR and they are well suited for confocal microscopy studies due to the flat 
morphology and the high cytosol/nucleus ratio. In some of the microscopy studies 
(mainly immuno-EM), human laryngeal carcinoma cells line Hep2 was chosen since 
these cells express higher levels of EGFR at the plasma membrane than do the HeLa 
cells. Higher EGFR level is an advantage due to the highly limited volumes/areas 
contained within an immuno-EM section compared to volumes examined by 
fluorescence microscopy. When studying the Y1045F-EGFR mutant (paper III) or the 
EGFR-Ub4 chimera (paper IV), PAE cells were used, either stably or transiently 
expressing the recombinant EGFR. PAE cells were used since they do not express 
endogenous EGFR and thereby enable investigation of the effect of an introduced 
alteration in the EGFR. As PAE cells do not express EGFR endogenously, it may be 
argued that the cells can exploit different mechanisms for endocytic down-regulation 
of the EGFR. However, the PAE cell line stably transfected with  wild type EGFR is 
well described and was reported to internalize EGFR at a level comparable to that of 
human cells endogenously expressing EGFR (Carter and Sorkin 1998).This cell line 
has since then been widely used as a model system to study endocytic down-
regulation of different mutant forms of EGFR as well as of other ErbB proteins (Jiang 
et al. 2003; Haslekas et al. 2005; Huang et al. 2006; Huang et al. 2007; Pedersen et al. 
2008).  
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One of the advantages of using immortalized cells is that these cells can be 
maintained in culture for a long time, thereby allowing several repeated experiments. 
On the other hand, genotypic or phenotypic alterations may occur after long times in 
culture, and the cells were therefore kept in culture for a limited time period. PAE 
cells stably transfected with wt- or Y1045F-EGFR were routinely tested for EGFR 
expression level and were not kept for more than 20 passages. 
4.2 TRANSIENT TRANSFECTION WITH PLASMIDS AND OVEREXPRESSION 
OF PROTEINS
Transfection of cells is a widely used and powerful tool for studying the importance 
of mutants or domains of a protein, or for detecting protein-protein interactions. 
Nevertheless, one should be aware of the pitfalls in this method. Transient 
transfection can result in artificially high levels of the encoded protein 
(overexpression) and may therefore cause cellular responses that have no 
physiological relevance. For example, altered stoichiometry may cause sequestration 
of endogenously expressed proteins. This was the case when epsin 1 was 
overexpressed in paper III (supplementary information). High levels of epsin 1, which 
possesses clathrin- and AP-2-binding motifs, disrupted clathrin-coated pits by 
sequestering AP-2 and clathrin away from the plasma membrane and thus inhibiting 
all endocytosis from clathrin-coated pits. In other cases, the effect of protein 
overexpression is useful. Overexpression of proteins, such as hSpry2 (used in paper II 
and III) or TULA (paper I), disrupts the interaction between Cbl and EGFR, thereby 
making it a useful tool to study the relevance of Cbl and/or ubiquitination in 
endocytosis of EGFR. One problem is that the transfection efficiency most often is 
low and that only a minority of the cells express the protein of interest. Thus, when 
performing biochemical analyses on a transiently transfected population of cells, the 
effect can easily be underestimated or even difficult to detect. 
4.3 RNA INTERFERENCE (RNAI)
RNAi is a tool to suppress mRNA levels and thereby the expression level of a protein 
of interest. The technique is based on the discovery that double-stranded small 
interfering RNAs (siRNAs) are a part of the post translational gene silencing in plants 
(Hamilton and Baulcombe 1999) as well as the finding that siRNAs also induce RNAi 
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in cultured mammalian cells (Elbashir et al. 2001). However, a pitfall in this 
technique is that RNAi may generate off-target effects, where the siRNAs, due to 
sequence similarity, reduce expression of non-targeted genes. To be sure that the 
observed phenotype is due to specific RNAi, it is useful to verify results by using 
siRNA sequences complementary to different regions of the mRNA-sequence 
transcribed from the same target gene. One should additionally be aware of the fact 
that introducing high amounts of siRNA to the cells may create an interferon response 
resulting in activation of intracellular signaling cascades (Sledz et al. 2003) which in 
turn may lead to misinterpretation of results. It is therefore important to transfect 
control cells with control siRNAs with similar length and identical concentration. In 
paper III where epsin I was knocked down using siRNAs, the control cells were 
treated with the transfection reagent only. However, we confirmed that under our 
experimental conditions, transfection of siRNA specific for a non-relevant gene 
(green fluorescent protein (GFP)) did not display the phenotype observed with the 
epsin 1 specific siRNAs (paper III, supplementary information). One should also be 
aware of the fact that it can be difficult to distinguish a direct effect of protein 
depletion from its indirect effects. For example, inhibiting endocytosis by siRNA-
mediated down-regulation of clathrin may prevent import of essential cells, thereby 
generating an indirect effect which in turn may cause an altered phenotype (Roth 
2008). Despite the limitations and pitfalls using RNAi, this method is a powerful 
technique to study the function of proteins.  
4.4 IMMUNOLOGICAL METHODS
In this work, several immunological techniques have been used. The prerequisite for 
all immunological methods is the specific interaction between an antibody and its 
antigenic epitope. Thus, it is important to include controls which ensure that the 
interaction is specific without immunoreactivity against irrelevant molecules. 
Western blotting was used to study protein level, formation of protein complexes and 
protein modifications, such as ubiquitination and phosphorylation. In this technique, 
the result exclusively depends on antibody-antigen interaction. Antibodies used in 
Western blotting were tested for specificity prior to use. Only antibodies recognizing 
proteins with the expected molecular weight were used. In addition, when it was 
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possible, antibody specificity was tested in cells overexpressing the protein of interest. 
This was assayed as increased intensity of the band detected by the antibody.  
 
Immunoprecipitation experiments were performed to purify proteins prior to analysis 
of protein modification and to study protein complex formation. In this method, 
antibodies are coupled to protein A or protein G which is pre-coupled to magnetic 
beads by the manufacturer. Proteins recognized by the antibody are then precipitated 
and isolated. It was tested whether the precipitation was specific for the protein of 
interest. This included a sample with protein A- or protein G-beads without antibody 
ruling out that the protein of interest was precipitated by unspecific interactions with 
the beads.  
 
Immunostaining of fixed cells was used to study intracellular localization of proteins 
and to detect protein expression levels upon transfection of cells with a plasmid 
encoding the protein of interest. The specificity of the antibodies used was also 
carefully tested by comparing the localization of the target protein with previous 
reports regarding the localization of the encoded protein as well as by including cells 
either not expressing or overexpressing the protein, whenever it was possible. All 
secondary antibodies used in this work were characterized in a control experiment 
using only secondary antibodies in order to investigate the level of background 
staining and to ensure that there was minimal unspecific binding. Prior to use in 
double or triple labeling experiments, different combinations of secondary and 
primary antibodies were tested for possible cross-reactions.    
4.5 MICROSCOPY
A major part of the research covered by this thesis is based on results obtained with 
confocal and electron microscopy. Confocal microscopy was used to study 
internalization of fluorescent ligands or antibodies, to study subcellular localization of 
proteins and to detect cells overexpressing proteins of interest. A major advantage of 
microscopical analysis is its possibility to study single cells. This is especially of 
interest in experiments involving transient transfection with plasmids, when not all 
cells express the protein of interest. However, results from single cells may display 
variations, and it is thus important to include several cells in the study to correct for 
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individual variations. It is thus useful to quantify cells displaying a certain phenotype 
and thereby obtain a more objective result. Such quantification was for example 
included in paper I, in which confocal microscopy was the only method used to 
analyze the effect of a mutant form of dynamin or TULA on internalization of 
different ligands and plasma membrane proteins.  
 
Immunofluorescent staining of proteins at the same subcellular localization was 
considered colocalization of these proteins. Our confocal microscopy analyses, 
however, only investigated localization in the x and y planes thereby allowing the 
possibility of superimposing in the z plane. We can therefore not be absolutely certain 
that the proteins reside in the same subcellular compartment based on these analyses, 
even though the images obtained strongly suggested colocalization. It should be 
pointed out that when cells were labeled with more than one antibody, the pictures 
were taken sequentially to avoid bleed-through from the distinct fluorochromes used.      
 
Since light microscopy has a relatively low resolution, immuno-EM was used to 
investigate the localization of proteins more precisely. In particular, the plasma 
membrane localization of EGFR before and after EGF-treatment under different 
experimental conditions was studied. One major advantage of immuno-EM is the high 
resolution achieved by this technique. Another important factor is that electron-dense 
protein coats at the plasma membrane can be detected without using specific markers. 
This has been useful in this kind of studies when localization of EGFR to clathrin-
coated areas at the plasma membrane has been a main focus. That these coats contain 
clathrin was confirmed by labeling for clathrin. A general problem in immuno-EM 
studies, however, is a limited labeling efficiency using EGFR antibodies combined 
with the small volumes contained within an EM-section (Griffiths 1993). Due to this, 
we often detect only one gold particle, i.e. one EGFR molecule in a single coated pit. 
Quantification of the results obtained using immuno-EM has thus been important, and 
in paper III we also included cell lines with higher expression of EGFR to confirm the 
results. Quantification was performed by counting gold particles localized to the 
plasma membrane followed by calculation of the percentage of the total labeling for 
EGFR at the plasma membrane that was associated with coated areas.  
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4.6 INTERNALIZATION OF EGF 
Different approaches to study internalization of EGF were used in this work. 
Internalization of EGF was used to indirectly study internalization of EGFR, since 
EGF is internalized when bound to its receptor. To measure the internalization ratio, 
cells were incubated with 1 ng/ml 125I-EGF. The amount of surface-labeled and 
internalized 125I-EGF at different time periods was measured, and the internalization 
ratio was calculated. This method is very sensitive, allowing small amounts of 
intracellularly localized EGF to be detected. It is thus particularly useful when 
studying internalization of EGFR at low EGF concentrations. To detect fluorescent 
EGF by confocal microscopy, however, higher concentrations of EGF were required. 
It could possibly be due to the low sensitivity of our system suggesting that multiple 
fluorescent EGF molecules have to coexist in endosomes to allow detection of the 
fluorescence signal above background level. In confocal microscopy studies included 
in this work, 10 ng/ml or 15 ng/ml of fluorescent labeled EGF were used, both of 
which are within the range of physiological concentrations of EGF (Sigismund et al. 
2005, supplementary Material). One exception though is in paper II where we used 
100 ng/ml EGF in order to study effects on macropinocytosis, which can be induced 
by high concentrations of EGF (Roepstorff et al. 2008). Detection of EGF using 
immuno-EM required high EGF concentration. This is probably due to a combination 
of the small volumes retained within an immuno-EM section and a limited labeling 
efficiency. We therefore incubated the cells with 60 ng/ml EGF prior to immuno-EM 
analyses. Moreover, 60 ng/ml EGF was routinely used in experiments where a cellular 
response to EGF-treatment (i.e. recruitment of proteins, posttranslational 
modifications and translocation of EGFR at the plasma membrane) was analyzed, in 
order to obtain a maximal response. 
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5 GENERAL DISCUSSION 
It is generally accepted that EGFR undergoes rapid clathrin-mediated endocytosis upon 
binding EGF. Despite the extensive investigation of EGFR endocytosis, the exact molecular 
mechanisms involved in this process are, however, not fully elucidated. There are 
conflicting reports regarding different posttranslational modifications required for EGFR 
endocytosis. Furthermore, there is also to some degree inconsistency in the literature 
concerning requirements for adaptor proteins and accessory endocytic proteins in 
translocation of activated EGFRs into clathrin-coated pits. 
 
5.1 SIGNALS FOR EGFR ENDOCYTOSIS
Receptors constitutively internalized from clathrin coated pits, such as TfR, are sorted to 
clathrin-coated pits via linear sequences such as tyrosine-based and di-leucine sorting 
signals selected by AP-2 (reviewed in Bonifacino and Traub 2003). EGFR also possesses 
linear sorting signals, both di-leucine and tyrosine-based. The tyrosine-based signal is 
demonstrated to interact with AP-2 (Nesterov et al. 1995; Sorkin et al. 1996), and the di-
leucine sequences have in a recent paper been reported to be essential for EGFR endocytosis 
(Wang et al. 2007). This is, however, in conflict with another report arguing that AP-2 is not 
strictly required as a cargo-selecting adaptor protein for EGFR, but that AP-2 is rather 
required as a clathrin-coat component having a more structural function (Johannessen et al. 
2006).  
 
In contrast to constitutively internalized receptors, EGFR is rapidly internalized only in 
response to ligand binding, and its endocytic signal is therefore most likely exposed or 
switched on by ligand-induced events, such as receptor dimerization, kinase activation, 
phosphorylation, and/or ubiquitination.  
 
5.1.1 Is EGFR kinase activity required for EGFR endocytosis? 
A recent paper argues that the EGFR kinase is dispensable for its internalization and 
moreover that receptor dimerization is sufficient to mediate endocytosis of EGFR (Wang et 
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al. 2005). This is, however, in conflict with several other reports demonstrating that 
endocytosis of EGFR is strictly dependent on the activity of the EGFR kinase. These reports 
are based on experiments using a kinase deficient mutant of EGFR or on the use of EGFR 
kinase inhibitors (Lamaze and Schmid 1995; Sorkina et al. 2002). Taking into consideration 
that overexpression of a dominant negative mutant of Grb2 efficiently inhibited EGF 
internalization (paper II) and that Grb2 is recruited to autophosphorylation sites on EGFR 
(Batzer et al. 1994), it is logical that kinase activity is required for EGFR endocytosis. This 
is supported by a previous paper from our group, where it was demonstrated that incubation 
with EGF induced formation of clathrin-coated pits, and that this was dependent on EGFR 
kinase activity (Johannessen et al. 2006). The role of Grb2 in EGFR endocytosis has been 
thoroughly investigated by the group of Alexander Sorkin. A recent paper revealed that the 
SH2-domain of Grb2 coupled to the RING-finger domain of Cbl was sufficient for restoring 
EGFR endocytosis in cells where endogenous Grb2 had been knocked down by RNAi, 
suggesting that an important function of Grb2 in EGFR endocytosis is to recruit Cbl to 
EGFR (Huang and Sorkin 2005). 
5.1.2 Is ubiquitination of EGFR necessary for its endocytosis? 
Upon EGF-binding, the EGFR is activated and becomes ubiquitinated by the ubiquitin 
ligase Cbl while still present at the plasma membrane (see Introduction, Section 1.1.3). 
However, whereas it is well established that ubiquitination of EGFR is a prerequisite for 
sorting EGFR to inner vesicles of MVBs, it is controversial whether ubiquitination is 
required for the initial steps of EGFR endocytosis (reviewed in Miranda and Sorkin 2007). 
In the work included in this thesis, there is consistently a correlation between inhibition of 
EGFR ubiquitination and inhibition of EGFR endocytosis. Moreover, a correlation between 
inhibited ubiquitination and inefficient translocation of EGFR into clathrin-coated pits has 
been observed. Overall, these data point in the direction of ubiquitination as a prerequisite 
also for initial steps of endocytic down-regulation of EGFR.  
 
In paper I, we used the Cbl-interacting protein TULA as a tool to investigate how impaired 
ubiquitination affected endocytosis of EGFR. It had previously been reported that 
ubiquitination and endocytic down-regulation of EGFR were both reduced upon 
overexpression of TULA (Feshchenko et al. 2004; Kowanetz et al. 2004). In paper I we 
additionally demonstrated that overexpression of TULA sequestered dynamin and thereby 
inhibited all dynamin-dependent endocytosis. It was therefore difficult to study how TULA 
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and its Cbl-interaction specifically affected endocytosis of EGFR. Since it further has been 
reported that TULA binds to Cbl via its SH3-domain and that the negative regulation of 
EGFR endocytosis is dependent on this interaction (Feshchenko et al. 2004; Kowanetz et al. 
2004), we mutated the SH3-domain of TULA. However, in conflict with the previously 
reported data, we found that the negative effect of TULA on ubiquitination and endocytosis 
of EGFR was independent of a functional SH3-domain (paper I). The reason for this 
discrepancy is unclear, but our data suggest either that Cbl can interact with TULA 
independently of the SH3-domain, or that TULA negatively impacts ubiquitination and 
endocytosis of EGFR regardless of Cbl binding.  
 
Correlation between inhibited ubiquitination and inhibited endocytosis of EGFR was also 
described in paper II, both by overexpression of the Cbl-interacting protein hSpry2 and 
overexpression of a dominant negative mutant of Grb2 not binding Cbl. In paper IV we 
further observed that inhibited endocytosis of EGF coincided with inhibited ubiquitination 
of EGFR in cells where c-Cbl and Cbl-b were knocked down by RNAi. This repeatedly 
observed correlation argues that ubiquitination and endocytosis of EGFR are linked. 
However, a correlation between ubiquitination and endocytosis is not direct evidence that 
ubiquitination of EGFR itself is necessary for its endocytosis. Also a correlation between 
ubiquitination of GHR and clathrin-mediated endocytosis of this receptor has been reported 
(Govers et al. 1997; Strous et al. 1997). Initially it was suggested that ubiquitination of the 
GHR was required for its endocytosis (Govers et al. 1997). However, it was later 
demonstrated that a domain of GHR designated ubiquitin-dependent endocytosis motif, 
rather than ubiquitination of GHR itself, was critical for its endocytosis (Govers et al. 1999). 
It was further suggested that this motif in GHR interacts with an E3 ubiquitin ligase which 
in turn mediates ubiquitination of another factor in the GHR-ubiquitination complex leading 
to GHR endocytosis (Govers et al. 1997; van Kerkhof et al. 2007). 
 
That the multidomain-containing protein and ubiquitin ligase Cbl is important in endocytic 
down-regulation of EGFR seems to be generally accepted (reviewed in Thien and Langdon 
2001). The question remains, however, whether it is the ubiquitin ligase activity or the 
domains involved in protein-protein interactions that is essential for its function in EGFR 
endocytosis. The finding of the RING-finger domain of Cbl being instrumental in EGFR 
endocytosis (Huang and Sorkin 2005) indicates that the ubiquitin ligase activity is essential 
for mediating EGFR endocytosis. However, it has yet not been clarified whether efficient 
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endocytosis of EGFR required Cbl-induced ubiquitination of the receptor itself or of an 
accessory endocytic protein. In paper II we made use of a ubiquitin mutant which could not 
be conjugated to substrates, but which could potentially bind to proteins harboring ubiquitin 
binding domains thereby disturbing their binding to ubiquitinated proteins. When this 
ubiquitin mutant was overexpressed, the EGF-induced endocytosis of EGFR was strongly 
inhibited (paper II). Again, this is not direct evidence that ubiquitination of EGFR itself is 
required for its endocytosis, but it strongly argues that the ubiquitin system is required for 
effective endocytosis of EGFR. If one or more endocytic adaptor proteins need to be 
ubiquitinated for endocytosis of EGFR, such candidates could potentially be Eps15 or epsin, 
both of which are demonstrated to be ubiquitinated in response to EGFR activation (van 
Delft et al. 1997; Polo et al. 2002). However, ubiquitination of these proteins is known to be 
mediated by ubiquitin ligases other that Cbl (Polo et al. 2002; Timsit et al. 2005), thereby 
making it unlikely that Cbl-mediated ubiquitination of either of these proteins is critical for 
EGFR endocytosis. However, we cannot rule out that ubiquitination of other, yet 
unidentified proteins, has a role in EGFR endocytosis.  
 
It was recently reported that ubiquitination of EGFR is not necessary for its endocytosis. 
This conclusion was based on the finding that an EGFR with multiple lysine mutations 
(designated 15KR), rendering it only marginally ubiquitinated, was internalized at a rate 
comparable to the rate of wild type EGFR (Huang et al. 2007). Moreover, internalization of 
the 15KR mutant of EGFR was sensitive to expression of both clathrin and Cbl, since 
depletion of clathrin heavy chain or of Cbl resulted in a reduced rate of internalization. 
From these findings, it was argued that Cbl is required to ubiquitinate another protein than 
EGFR itself. It should, however, be noted that the mutant EGFR used in this reported work 
contained residual lysine residues that could possibly be targets for ubiquitination and 
further that complete absence of ubiquitination of the EGFR mutant could not be achieved. 
A residual ubiquitination of approximately 1 % was reported (Huang et al. 2007). A 
problem when investigating ubiquitination level of proteins by Western blotting is that 
marginal ubiquitination can be difficult to detect. It was recently reported that an antibody to 
polyubiquitin did not show linear reactivity since the quantitative Western blotting did not 
correspond to the amount of ubiquitinated proteins added to the gel (Umebayashi et al. 
2008). To what extent this is the case for other anti-ubiquitin antibodies as well is unknown, 
but this could potentially explain some of the discrepancy in the literature regarding the 
level of ubiquitination of EGFR versus the rate of endocytosis.  
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Ubiquitination has been demonstrated to be a prerequisite for internalization of several cell 
surface receptors in both yeast and mammalian cells (Galan et al. 1996; Hicke and Riezman 
1996; Galan and Haguenauer-Tsapis 1997; Geetha et al. 2005; Belouzard and Rouille 2006; 
Miranda et al. 2007). Since our results suggested that ubiquitination is important for EGFR 
endocytosis, we wanted to investigate whether ubiquitin could induce endocytosis of the 
EGFR in the absence of added ligand or of the EGFR kinase activity (paper IV). Based on 
experiments with the EGFR-Ub4 chimeric protein in which 4 ubiquitin moieties were 
recombinantly fused to the C-terminus of EGFR via a flexible linker, we could indeed 
demonstrate that ubiquitin per se promoted clathrin-dependent endocytosis of EGFR. 
Chimeric proteins of EGFR and ubiquitin have been described earlier (Haglund et al. 2003; 
Mosesson et al. 2003; Sigismund et al. 2005). A chimeric protein consisting of one single 
ubiquitin fused to a truncated EGFR consisting of the transmembrane and extracellular parts 
was reported to be internalized in a clathrin-independent, but caveolin-dependent, manner. 
The view of ubiquitination as signal for caveolae-mediated endocytosis has later been 
argued against by data from Barriere et al. (Barriere et al. 2006). By RNAi they 
demonstrated that endocytosis of ubiquitinated cargo was clathrin-dependent and caveolin-
independent. This is in accordance with our finding that endocytosis of the EGFR-Ub4 
depended on clathrin. The different conclusions in these studies could possibly be explained 
by the differences in the chimeric fusion proteins used. Sigismund et al studied a truncated 
version of EGFR with one single ubiquitin as the intracellular signaling unit (Sigismund et 
al. 2005). In contrast, we used a full length EGFR. Moreover, since the endocytic adaptors 
containing UIMs, epsin 1 and eps15, preferably interact with polyubiquitin chains 
(Hawryluk et al. 2006), we fused 4 ubiquitins to the EGFR. Interestingly, the observation 
that 4 ubiquitins is sufficient to mediate clathrin-dependent endocytosis of EGFR argues 
that the EGFR does not necessarily need to be heavily ubiquitinated to bind endocytic 
adaptor proteins via ubiquitin binding domains. This challenges the conclusion that EGFR 
ubiquitination is not necessary for its endocytosis based on the finding that the 15KR EGFR 
mutant was endocytosed as effectively as was the wild type EGFR (Huang et al. 2007).  
 
Altogether, our data suggest that ubiquitination plays an important role in endocytosis of 
EGFR. However, how the ubiquitinated EGFR interacts with adaptor proteins and which 
adaptor proteins are required are still not fully resolved.  
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5.2 TRANSLOCATION OF EGFR INTO CLATHRIN-COATED PITS
As described, EGFR is mainly endocytosed from clathrin-coated pits. The molecular 
mechanisms and the adaptor proteins involved in the translocation of EGFR into clathrin-
coated pits are not fully elucidated. In paper II we demonstrated that a fraction of the plasma 
membrane localized EGFR was translocated from smooth areas to clathrin-coated areas at 
the plasma membrane upon incubation of cells with EGF. Since the EGF-induced 
endocytosis of EGFR is a rapid process at 37 °C, we performed experiments on ice as it was 
previously reported that maximal accumulation of EGFR in clathrin coated pits was 
observed at 4 °C (Sorkina et al. 2002). This allowed us to study the involvement of specific 
proteins in recruitment of activated EGFR into clathrin-coated pits. Upon EGF-treatment, 
we detected a relocalization of Cbl, Grb2 and Eps15 from the cytosol to the plasma 
membrane. By immuno-EM studies, we could demonstrate in more detail that Cbl and Grb2 
both localized to the rim of clathrin-coated pits upon EGF-treatment, suggesting that these 
proteins participate in the recruitment of activated EGFR to clathrin-coated pits. The finding 
that the nonconjugable ubiquitin mutant inhibited recruitment of activated EGFR to clathrin-
coated pits further suggested that interaction between ubiquitinated proteins and proteins 
with ubiquitin binding domains is important in this process. Consistently, when EGF-
induced ubiquitination of EGFR was inhibited by overexpression of the Cbl-binding protein 
hSpry2, the translocation of EGFR into clathrin-coated pits was inhibited, and the activated 
EGFR was retained at the rim of clathrin-coated pits. This observation led us to speculate 
that ubiquitination mediates translocation of EGFR from the rim to inner parts of clathrin-
coated pits. In paper IV this hypothesis was further investigated. When c-Cbl and Cbl-b 
were knocked down by RNAi and the ubiquitination of EGFR was strongly inhibited, less 
EGFR was associated with clathrin-coated pits. Moreover, the distribution of EGFR within 
clathrin-coated pits was affected by knockdown of c-Cbl and Cbl-b. Coat-associated EGFR 
from cells depleted of c-Cbl and Cbl-b localized predominantly to the rim of the coats, 
whereas the coat-associated EGFR mainly was found in the interior of the coated pits in 
control cells (paper IV). 
 
The adaptor complex AP-2 is a key component in clathrin-coated pits due to its clathrin-
binding and its direct binding to several cargo proteins, as well as to its ability to recruit 
endocytic accessory proteins (Conner and Schmid 2003b). However, the involvement of 
AP-2 in endocytosis of EGFR has been disputed, and different requirements for this adaptor 
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complex in EGFR and TfR endocytosis have been reported (Conner and Schmid 2003a; 
Motley et al. 2003; Johannessen et al. 2006). If EGFR needs to be ubiquitinated to be 
effectively translocated from the rim to interior parts of clathrin-coated pits, this 
translocation probably requires one or more adaptor proteins that contain ubiquitin binding 
domains. Two such candidate proteins harboring UIMs are Eps15 and epsin (Hofmann and 
Falquet 2001). Eps15 has previously been shown to localize to the rim of clathrin-coated 
pits (Tebar et al. 1996; Stang et al. 2000). It is thus unlikely that this protein sequesters 
ubiquitinated EGFR in the interior parts of the coated pits. In contrast, epsin 1 was found to 
localize all along the clathrin-coats, both in flat and in invaginated coated areas (paper II). 
Moreover, siRNA-mediated depletion of epsin 1 inhibited both recruitment of activated 
EGFR into interior parts of clathrin-coated pits and endocytosis of EGF to the same extent 
(paper III). We additionally demonstrated that epsin 1 and EGFR interacted in a ubiquitin- 
and UIM-dependent manner. In paper III, we therefore proposed a model in which Eps15 
and epsin 1 cooperate in packaging of ubiquitinated EGFR into the invaginated section of 
clathrin-coated pits. Our model is that ubiquitinated EGFR binds transiently to Eps15 and is 
subsequently handed over to epsin 1 which is localized inside the edge of the clathrin-coat. 
This resembles the described cooperation of GGAs (Golgi-associated, -adaptin 
homologues) and AP-1 in packaging of Mannose-6-Phosphate receptors at the TGN (Doray 
et al. 2002). It should be noted that we in paper II reported that not all EGF-positive 
clathrin-coated pits were epsin 1-positive, which could suggest that also other ubiquitin 
binding proteins could function as adaptors for ubiquitinated EGFR. However, a later study 
has shown that epsin 1 is present in all clathrin-coated pits (Hawryluk et al. 2006). Our 
conclusion may thus be a misinterpretation explained by limited labeling efficiency for 
epsin 1 as discussed in Section 4.5. Our data demonstrating that epsin 1 depletion inhibited 
recruitment of ubiquitinated EGFR into the interior of clathrin-coated pits are consistent 
with previous reports suggesting that epsin 1 is involved in endocytosis of ubiquitinated 
cargo (Barriere et al. 2006) and that epsin 1 is involved in clathrin-mediated endocytosis 
(Hawryluk et al. 2006). It has, however, been argued against epsin as adaptor protein for 
ubiquitinated cargo in clathrin-mediated endocytosis based on data suggesting that the 
ubiquitin binding and clathrin binding capacity of epsin 1 were mutually exclusive (Chen 
and De Camilli 2005) and that epsin 1 was involved in caveolae-mediated endocytosis 
(Sigismund et al. 2005). However, the work presented by Hawryluk et al. demonstrating that 
epsin 1 colocalized with AP-2 and not with caveolin argues against this conclusion 
(Hawryluk et al. 2006). 
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Upon RNAi-mediated epsin 1 knock down, we observed a reduced EGF internalization ratio 
of approximately 30 % compared to in control cells (paper III). The relatively low effect of 
epsin 1 depletion can possibly be explained by incomplete epsin 1 knock down, or it can be 
argued that epsin 1 is not strictly required for EGFR endocytosis. We can thus not exclude 
the possibility that other unidentified UIM-containing proteins or epsin 2 can mediate 
translocation of ubiquitinated EGFR into clathrin-coated pits (as suggested in paper II). If 
epsin 1 is not strictly required for EGFR endocytosis, it could, however, possibly act by 
facilitating or speeding up endocytosis of the ubiquitinated EGFR.  
 
5.3 CONCLUDING REMARKS
This work has shown that: 
o Grb2 and c-Cbl localize to the rim of clathrin-coated pits upon activation of EGFR 
and these proteins are both involved in endocytosis of EGFR 
o there is correlation between inhibited ubiquitination and inhibited endocytosis of 
EGFR  
o when ubiquitination of EGFR was inhibited by different means, activated EGFR 
was less efficiently recruited into interior parts of clathrin-coated pits  
o ubiquitin recombinantly added to EGFR promoted internalization of EGFR from 
clathrin-coated pits 
o there is a positive correlation between expression of epsin 1 and localization of 
EGFR into interior parts of clathrin-coated pits  
 
Based on these data, I suggest the following model: upon incubation of cells with EGF, 
the EGFR dimerizes and the EGFR kinase is activated leading to recruitment of Grb2 
and Cbl to EGFR and the EGFR is translocated to clathrin-coated areas at the plasma 
membrane. Cbl-mediated ubiquitination of EGFR, which occurs at the plasma 
membrane, facilitates the recruitment of EGFR into interior parts of clathrin-coated pits 
by ubiquitinated EGFR interacting sequentially with Eps15, localized at the rim of 
clathrin-coated pits, and epsin 1 which sequesters ubiquitinated EGFR in interior parts 
of clathrin-coated pits, from where EGFR is endocytosed. 
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